Euprolactinemic gynecomastia and galactorrhea with risperidone-fluvoxamine combination

P. J. Pratheesh, Samir Kumar Praharaj, Ashish Srivastava

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Risperidone is associated with hyperprolactinemia and its consequent symptoms such as gynnecomastia, galactorrhea and sexual dysfunction in adults, and less so in adolescents. Rarely, serotonin reuptake inhibitors are also associated with such adverse effects.We report a case of gynecomastia and galactorrhea in an adolescent male while on a combination of risperidone and fluvoxamine, although the serum prolactin was within normal range.

Original languageEnglish
Pages (from-to)70-73
Number of pages4
JournalPsychopharmacology Bulletin
Volume44
Issue number1
Publication statusPublished - 30-11-2011

Fingerprint

Galactorrhea
Fluvoxamine
Gynecomastia
Risperidone
Hyperprolactinemia
Serotonin Uptake Inhibitors
Prolactin
Reference Values
Serum

All Science Journal Classification (ASJC) codes

  • Psychiatry and Mental health
  • Pharmacology (medical)

Cite this

@article{6b56835125064e4fbe6c7605c990bffd,
title = "Euprolactinemic gynecomastia and galactorrhea with risperidone-fluvoxamine combination",
abstract = "Risperidone is associated with hyperprolactinemia and its consequent symptoms such as gynnecomastia, galactorrhea and sexual dysfunction in adults, and less so in adolescents. Rarely, serotonin reuptake inhibitors are also associated with such adverse effects.We report a case of gynecomastia and galactorrhea in an adolescent male while on a combination of risperidone and fluvoxamine, although the serum prolactin was within normal range.",
author = "Pratheesh, {P. J.} and Praharaj, {Samir Kumar} and Ashish Srivastava",
year = "2011",
month = "11",
day = "30",
language = "English",
volume = "44",
pages = "70--73",
journal = "Psychopharmacology Bulletin",
issn = "0048-5764",
publisher = "MedWorks Media LLC",
number = "1",

}

Euprolactinemic gynecomastia and galactorrhea with risperidone-fluvoxamine combination. / Pratheesh, P. J.; Praharaj, Samir Kumar; Srivastava, Ashish.

In: Psychopharmacology Bulletin, Vol. 44, No. 1, 30.11.2011, p. 70-73.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Euprolactinemic gynecomastia and galactorrhea with risperidone-fluvoxamine combination

AU - Pratheesh, P. J.

AU - Praharaj, Samir Kumar

AU - Srivastava, Ashish

PY - 2011/11/30

Y1 - 2011/11/30

N2 - Risperidone is associated with hyperprolactinemia and its consequent symptoms such as gynnecomastia, galactorrhea and sexual dysfunction in adults, and less so in adolescents. Rarely, serotonin reuptake inhibitors are also associated with such adverse effects.We report a case of gynecomastia and galactorrhea in an adolescent male while on a combination of risperidone and fluvoxamine, although the serum prolactin was within normal range.

AB - Risperidone is associated with hyperprolactinemia and its consequent symptoms such as gynnecomastia, galactorrhea and sexual dysfunction in adults, and less so in adolescents. Rarely, serotonin reuptake inhibitors are also associated with such adverse effects.We report a case of gynecomastia and galactorrhea in an adolescent male while on a combination of risperidone and fluvoxamine, although the serum prolactin was within normal range.

UR - http://www.scopus.com/inward/record.url?scp=82155178476&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=82155178476&partnerID=8YFLogxK

M3 - Article

VL - 44

SP - 70

EP - 73

JO - Psychopharmacology Bulletin

JF - Psychopharmacology Bulletin

SN - 0048-5764

IS - 1

ER -